Description of the data source, numerator, denominator, survey questions, and other relevant details about the national estimate.
Number of females aged 13 to 15 years receiving at least 3 doses of the human papillomavirus (HPV) vaccine
Number of females aged 13 to 15 years
NIS-Teen collects vaccination information for adolescents aged 13–17 years in the 50 states, the District of Columbia, selected areas, and the U.S. Virgin Islands, using a random-digit–dialed sample of landline and, starting in 2011, cellular telephone numbers. Parent/guardian respondents provide vaccination and sociodemographic information on adolescents in their care. After the parent/guardian grants permission to contact their child's vaccination provider, a questionnaire is mailed to that provider to obtain a vaccination history from the medical record. Data for this measure were restricted to adolescents aged 13–15 and weighted to represent the population of adolescents age 13-15, with adjustments for households with multiple telephone lines and mixed telephone use (landline and cellular), household nonresponse, and exclusion of households without telephone service.
In 2007, the Advisory Committing on Immunization Practices (ACIP) recommended a routine 3-dose series of human papillomavirus vaccination for females age 11-12 years and catch-up vaccination for females aged 13-26 years who have not been previously vaccinated. The vaccination may be initiated as early as nine years of age and should be administered before potential exposure to HPV through sexual contact.
This measure tracks the proportion of female adolescents aged 13–15 years receiving at least 3 doses of the quadrivalent or bivalent human papillomavirus vaccine.
Additional resources about the objective.
This hyperlink will direct you to a non-governmental Website or application.
The appearance of external hyperlinks does not constitute endorsement by the United
States Department of Health & Human Services (HHS) of the hyperlinked Website
or application, or the information, products or services contained therein. Such
hyperlinks are provided consistent with the intended purpose of this HHS Website.
Visitors to the hyperlinked Website or application will be subject to the Website
or application's privacy policies. These practices may be different than those of
this HHS Website.
You will be redirected to: link